Completed
A Single-dose Study to Investigate the Tolerance and Pharmacokinetics of Finamine Tablets in China
NCT04162275
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Shijiazhuang Yiling Pharmaceutical Co. Ltd Shijiazhuang, Hebei, China